Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study
Clinical trial NCT04890236 · COMPLETED
Trial details
- NCT number
- NCT04890236
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-13
- Primary completion
- 2024-03-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.